Friday, 15 Dec 2017

RA/Inflammatory arthritis

Datesort ascending Type Title Save
04 Nov 2017 Social RT @_connectedcare: The vascular damage in Secondary Raynauds leads to the ischaemic damage #acr17
04 Nov 2017 Social RT @DrBhana: 2016 Sjogrens Classification Criteria #acr17
04 Nov 2017 Social RT @philipcrobinson: New Sjogren syndrome antibodies #ACR17
04 Nov 2017 Social RT @cgytz: Possible new antibodies in early #sjogrens syndrome #ACR17
03 Nov 2017 Social Lg Canada RA study shows Rx D/C incr w/ MD Global, NSAID, #DMARD; but continuation best w/ married, RF+, comorbidity
01 Nov 2017 News High Volume Lyme Disease Reporting in Low Incidence Arkansas
31 Oct 2017 Social Taiwan claims database shows risk of CV events in RA lower w/ topical NSAIDs (1.87/100PY) vs oral NSAIDs(2.14/100PY)
28 Oct 2017 Social RA Matters survey- Canadians show RA impacts relationships (40%); half affected career/retirement; 2/3 less exercise
26 Oct 2017 News RABBIT Risk Scores are Higher in ICU-Admitted RA Patients
26 Oct 2017 Social Atherosclerosis assessed by CIMT in 46 RA pts showed tofacitinib to improve CIMT, despite potential to incr lipids.
26 Oct 2017 Social Claims data on RA pts shows better persistence w/ MOA switchers vs TNFi cyclers (48% v 40%) & lower healthcare costs
26 Oct 2017 Social UK's NICE approves Tofacitinib for use in RA not responding to DMARD Rx - as mono or combo Rx w/ MTX.
25 Oct 2017 News Does Birth Control or Breastfeeding Reduce RA Risk?
20 Oct 2017 Social Prof. J Bijlisma presents U-ACT trial in very early RA. Shows MTX + TCZ leads to early sustained remission, chance…
19 Oct 2017 Social Of the ~65% early RA pts on low dose pred (3.1mg/d) x7 yrs had more NSAIDs, DMARD, biologics, Dz activity, CRP & CCP
17 Oct 2017 Social 10 pts on immune Checkpoint inhib- 6 got seropositive RA, 4PMR, 1-9 mos after Rx, all Rx steroids or DMARDs
12 Oct 2017 Social Rare Antimalarial cardiomyopathy 47 cases seen in RA & SLE, w/ 45% mortality, presents as CHF, syncope or AV Block.
12 Oct 2017 Social 1491 RA pts in REGATE study - 1st SIE rate 4.9/100PY. Increased SIE risk w/ LEF, high DAS28, ACPA neg, ANC >5000.
12 Oct 2017 Social prospective 16wk study of NSAID W/D in RA w/ DAS<3.2-85% success w/o change in DAS28 or PRO, esp in those w/ SJC=0
10 Oct 2017 Social RT @_connectedcare: Breastfeeding in rheumatoid: more data showing Cimzia use is safe